Cabaletta Bio Inc

Research Cabaletta Bio Inc (CABA) on Bullrun: market cap USD 507.10M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCABA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 507.10M
• Financial periodFY2025
• Net income-USD 167.86M
• Free cash flow-USD 132.31M

Valuation Snapshot

latest market cap is USD 507.10M.

About Cabaletta Bio Inc

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases.

Frequently asked questions

What is Cabaletta Bio Inc's market cap?

Cabaletta Bio Inc's market capitalization is USD 507.10M.

What does Cabaletta Bio Inc do?

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases.